Merrill Lynch Co analyst Richard Vietor reiterate buy recommendation drug stock today. The stock Bristol-Myers Co BMY> rise 2-1/4 101 Schering-Plough Corp SGP> 2-7/8 97 Syntex Corp SYN> 1-3/8 82. Vietor described stock "middle group" performers. Vietor price stock "look pretty cheap relative lead performer drug Upjohn Co UPJ> Merck Co Inc MRK> Squibb Corp SQB>." Vietor mention Pfizer Inc PFE> 72-3/4 Warner-Lambert Co WLA> 1-1/2 74-1/2 middle group. But recommend stock rate neutral. Reuter 